Skip to content
P&G Hygiene and Health Care logo

P&G Hygiene and Health Care

Procter & Gamble Hygiene and Health Care Ltd

PGHH NSE
₹7,020.00 +98.00 (+1.42%)
Market Cap
₹22,787 Cr
P/E
29.34
View as Markdown
MCP
Close 20 Nov 2026 ₹7,020.00 1Y −5,816.00 −45.3%
Start ₹12,836.00

Key Fundamentals

SmallcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
157.00%
Debt to Equity
0.00
EPS (TTM)
₹239.27
Book Value
₹272.33
Market Cap
₹22,787 Cr
P/E (TTM)
29.34
P/B
25.78
ROE
115.00%
Dividend Yield
3.68%
EBITDA
₹1,214 Cr
52W High
₹13,156.00
52W Low
₹6,579.00
Day Range
₹6,897.50 – ₹7,259.00
Volume
22,680

Peer Comparison

Fast Moving Consumer Goods › Personal Products › Personal Care

P&G Hygiene and Health Care peer comparison
919.5047.5794,0937.461.67%16.10%18.80%16,5371,978
393.1034.4269,7346.070.92%17.00%20.30%13,9242,001
365.65290.2049,16887.481.38%27.60%33.90%602169
1,760.0035.1547,86929.601.42%82.70%108.00%6,3911,362
7,090.5033.8023,10521.513.31%66.50%90.70%3,211683
7,020.0029.3422,78725.783.73%115.00%157.00%4,240776
422.2024.7618,4296.301.21%26.20%28.10%4,204747
Median 7 companies919.5034.4247,86921.511.42%27.60%33.90%4,240776

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

52 Average

Data confidence 100/100

Category scores

Quality
92
Strong
Returns, margins, earnings quality 22% weight
Valuation
40
Weak
Cheap vs sector & own history 24% weight
Growth
30
Poor
Sales & profit trajectory 9% weight
Financial Health
91
Strong
Solvency, leverage, coverage 9% weight
Momentum
17
Poor
Trend strength, vol-adjusted 12% weight
Ownership
38
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 3.28%.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 89.4%
  • Company has been maintaining a healthy dividend payout of 91.5%

Weaknesses

2
  • Stock is trading at 25.8 times its book value
  • The company has delivered a poor sales growth of 7.40% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish775
OscillatorsBullish072
Moving AveragesStrong Bearish703

Key readings

RSI (14)
50.13
Neutral
MACD (12,26,9)
−29.61
Bullish
SMA (50)
7,057.51
Bearish
SMA (200)
8,981.16
Bearish

As of

Analyst Rating

Based on 3 analysts
BUY67%

2 of 3 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
2
67%
HOLD
1
33%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+27.15%
TTM−2.03%

Net profit

Net profit growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+34.38%
TTM−6.17%

Operating cash flow

Operating cash flow growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+54.52%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+1.48 pp
TTM−1.39 pp

Revenue by year

Revenue by year, ₹ crore
Jun 2017₹2,320 Cr
Jun 2018₹2,455 Cr
Jun 2019₹2,947 Cr
Jun 2020₹3,002 Cr
Jun 2021₹3,574 Cr
Jun 2022₹3,901 Cr
Jun 2023₹3,918 Cr
Jun 2024₹4,206 Cr
Mar 2025₹3,374 Cr
Mar 2026₹4,290 Cr

Net profit by year

Net profit by year, ₹ crore
Jun 2017₹433 Cr
Jun 2018₹375 Cr
Jun 2019₹419 Cr
Jun 2020₹433 Cr
Jun 2021₹652 Cr
Jun 2022₹576 Cr
Jun 2023₹678 Cr
Jun 2024₹675 Cr
Mar 2025₹637 Cr
Mar 2026₹856 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹382 Cr +37.8% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk high

Procter & Gamble Hygiene and Health Care Ltd trades at ₹6,988.50 as of 2026-11-17 with a market cap of ₹22,685 crore. The company is virtually debt-free with an exceptionally high ROE of 113.67% and ROCE of 135.44%, but the stock has declined 46% over the past year and currently trades 47% below its 52-week high of ₹13,156, while TTM sales and profit growth have turned negative.

Bull Case 7
  • The company is essentially debt-free with a debt-to-equity ratio of 0, providing significant financial flexibility and resilience across economic cycles.
  • ROE stands at an extraordinary 113.67% as of 2026-11-17, with a 3-year average ROE of 89% and last year's ROE at 115%, indicating highly efficient capital utilisation.
  • ROCE of 135.44% reflects exceptional returns on total capital employed, among the highest in the FMCG sector.
  • Dividend yield of 3.71% as of 2026-11-17 is notably generous for an FMCG company, supported by a healthy dividend payout ratio of 91.5%.
  • Compounded profit growth of 14% over both 3-year and 5-year periods demonstrates a sustained earnings trajectory despite recent softness.
  • The stock trades at ₹6,988.50, just 6% above its 52-week low of ₹6,579, which may indicate that much of the negative sentiment is already reflected in the price.
  • Backed by a global FMCG parent with deep expertise in hygiene and health care categories, the company operates in segments with structural long-term demand in India.
Bear Case 8
  • The stock is trading at 25.66 times book value as of 2026-11-17, an elevated valuation that leaves little margin for error.
  • TTM sales growth has turned negative at -2%, a sharp deceleration from the 5-year compounded sales growth of 7% and 10-year rate of 6%.
  • TTM profit growth is -6%, reversing the positive trend seen over the 3-year (14%) and 5-year (14%) compounding periods.
  • The stock has delivered a 1-year return of -46% and a 10-year CAGR of just 1%, indicating prolonged destruction of shareholder value relative to broader market returns.
  • Five-year sales CAGR of 7% is modest for a consumer goods company operating in a high-growth emerging market like India.
  • The stock has fallen 47% from its 52-week high of ₹13,156 to ₹6,988.50, reflecting a severe de-rating and loss of market confidence.
  • Even the 3-year and 5-year stock CAGRs are deeply negative at -28% and -14% respectively, suggesting structural concerns beyond short-term earnings volatility.
  • A PE of 29.21 on TTM earnings, while the company is experiencing negative top-line and bottom-line growth, suggests the valuation may not yet fully account for the earnings slowdown.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

21h ago

TL;DR: A quiet period for P&G Hygiene with no major operational news. The resolution of a long-pending transfer pricing dispute (FY11-FY19) is a net positive, trimming contingent liabilities by ₹94 crore at a cost of just ₹14.3 crore. No fresh headwinds have emerged. Watch for upcoming quarterly results and any demand commentary in the FMCG space for forward direction.

Positives 1
  • Contingent liabilities cut ₹94Cr Nov 17

    P&G Hygiene settled a transfer pricing dispute covering FY11-FY19, reducing contingent liabilities by ₹94 crore — a meaningful cleanup of the balance sheet.

Neutral 1
  • TP settlement costs ₹14.3Cr Nov 17

    The settlement required a one-time payment of ₹14.3 crore to resolve the transfer pricing dispute, a modest outflow relative to the ₹94 crore reduction in contingent liabilities.

Quarterly Results

₹ Cr
PGHH quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
1,138
1,133
1,002
932
1,135
1,248
992
937
1,150
1,262
941
891
1,145
Expenses
853
824
745
813
845
877
782
671
865
860
723
721
885
Operating Profit
285
310
257
118
290
371
210
266
285
402
218
170
260
OPM %
25%
27%
26%
13%
26%
30%
21%
28%
25%
32%
23%
19%
23%
Other Income
16
16
14
7
8
10
19
8
10
12
12
9
17.01
Interest
2
3
22
0
2
7
6
0
4
3
3
0
3.67
Depreciation
14
14
15
13
12
10
10
9
9
10
10
10
11.44
PBT
284
309
234
112
285
364
213
265
282
402
218
170
262
Tax %
26%
26%
34%
28%
26%
26%
27%
27%
26%
25%
30%
26%
25%
Net Profit
211
229
154
81
212
269
156
192
210
301
153
126
196
EPS (₹)
64.91
70.52
47.56
24.97
65.28
82.74
48.09
59.17
64.65
92.87
47.17
38.90
60.33
YoY Sales growth
9
0
13
9
0
10
−1
1
1
1
−5
−5
0

Profit & Loss

₹ Cr
PGHH profit and loss, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Sales
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
3,374
4,290
4,240
Expenses
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
2,503
3,119
3,189
Operating Profit
495
608
675
622
618
606
886
832
869
976
871
1,171
1,050
OPM %
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
26%
27%
25%
Other Income
64
85
67
18
45
42
39.38
23
40.58
47
37
42
51
Interest
6
6
10
5
5
6
6
11
11
27
14
9
10
Depreciation
53
52
60
52
50
48
48
53
58
56
32
37
40
PBT
501
636
672
582
607
594
870
790
839
939
862
1,167
1,052
Tax %
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
26%
27%
—
Net Profit
346
422
433
375
419
433
652
576
678
675
637
856
777
EPS (₹)
106.63
130.16
133.31
115.40
129.12
133.42
200.79
177.37
208.91
207.95
196.11
263.86
239.27
Div. Payout %
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
89%
97%
—
Sales growth
14
−2
2
6
20
2
19
9
0
7
−14
27
−2

Balance Sheet

₹ Cr
PGHH balance sheet, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026Sep 2026
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
1,196
1,619
494
773
877
1,125
682
705
914
742
705
721
852
Borrowings
0
0
0
0
0
0
3
5
4
3
2
1
0
Other Liabilities
719
515
634
620
708
671
915
940
1,187
1,081
1,015
1,049
1,245
Total Liabilities
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
2,129
Fixed Assets
309
317
286
250
234
206
184
164
170
139
131
163
163
CWIP
39
35
41
21
15
22
38
44
23
28
41
21
28
Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,600
1,814
834
1,154
1,368
1,600
1,411
1,475
1,945
1,692
1,583
1,619
1,939
Total Assets
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
2,129

Cash Flow

₹ Cr
PGHH cash flow, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating
426
352
445
415
413
474
863
573
826
470
598
924
Investing
28
221
149
−19
34
75
7
−27
−10
1
−34
11
Financing
−105
−122
−1,559
−106
−314
−190
−1,106
−569
−477
−861
−671
−845
Net Cash Flow
349
452
−964
290
134
358
−236
−23
339
−390
−107
91
Free Cash Flow
348
300
401
377
410
423
832
523
781
427
544
893
CFO/EBITDA
127
91
103
111
105
102
126
99
121
79
96
105

Ratios

PGHH financial ratios, annual
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Debtor Days
18
24
21
22
22
20
15
18
20
21
33
21
Inventory Days
47
53
71
48
60
68
78
55
48
51
64
51
Days Payable
148
134
145
156
162
175
237
183
213
193
235
197
Cash Conversion Cycle
−83
−57
−53
−87
−79
−87
−144
−110
−145
−121
−138
−126
Working Capital Days
4
8
−15
−23
−12
−21
−39
−34
−53
−32
−30
−31
ROCE %
46%
45%
64%
89%
73%
58%
94%
110%
101%
112%
104%
157%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view P&G Hygiene and Health Care insights

63 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 70.64%
  • DIIs 15.04%
  • Public 10.83%
  • Others 2.88%
  • FIIs 0.62%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about P&G Hygiene and Health Care

What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses.
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd trades as PGHH on the NSE and under code 500459 on the BSE.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd is classified under the Fast Moving Consumer Goods sector, in the Personal Products industry.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of ₹22,787 Cr as of 20 Nov 2026, which places it in the Smallcap band.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd trades at a PE ratio of 29.34 as of 20 Nov 2026, on earnings per share of ₹239.27, against a book value of ₹272.33 per share.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the last 52 weeks Procter & Gamble Hygiene and Health Care Ltd has traded between ₹6,579 and ₹13,156 as of 20 Nov 2026.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.68%.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd reported a return on equity of 115.00%. Its debt-to-equity ratio is 0.00.

Company Information

Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.

Website pg.com/en_IN
Listed 7 Jul 2004
Face Value ₹10
Shares Outstanding 3,24,60,736

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PGHH.md for Procter & Gamble Hygiene and Health Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More